• 180+

    The UK’s most active investor in UK university spin-outs

  • £500M

    Over £500m raised; invested into over 180 companies

  • £145M

    Cash returned to investors via exits

  • £1.2Bn

    Part of FTSE 250 sector specialist group with £1.2bn net assets

About Parkwalk

Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class returns.

Performance

We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.

Learn More

Parkwalk Open Funds

Parkwalk offer early-stage investment funds, investing in high-growth, knowledge intensive companies spun out of the UK’s world-leading universities and providing tax benefits under the Enterprise Investment Scheme.

Opportunities EIS Fund

Our evergreen EIS Fund, investing in EIS-qualifying hard science and deep tech companies spun out of universities across the UK.
Learn More

Imperial College Enterprise Fund III

Our ICEF III invests in high-growth, IP-rich technologies linked to Imperial College.
Learn More

Meet the Parkwalk team

Combining our diverse range of skills and experience with integrity and transparency the Parkwalk team has an outstanding track record for supporting high-growth innovation that delivers returns.

Alun Williams
Ian Broadhurst
Chloe Woodacre
Meet the team

Empowering Innovation

Parkwalk Funds invest in dynamic university spin-out companies seeking to commercialise intellectual property and technology. From investing in seed to later stage companies, we help fantastic management teams develop and build world-class successful businesses.

Fuel 3D Technologies

Fuel 3D has developed proprietary algorithms, software and 3D hardware platforms that deliver extremely high quality 3D shape and colour capture for a range of retail and pharmaceutical applications. The Fuel3D Biovolume scanner is a point-and-shoot 3D scanning system that accurately captures and reconstructs 3D tumour surface changes, enabling the analysis of texture, colour, shape

Carbometrics

Carbometrics is a specialist supramolecular chemistry company. Carbometrics’ core technology is a synthetic molecule that was intricately designed to bind to glucose – A Glucose Binding Molecule (GBM) – which is being used to develop a new glucose sensor chemistry that can help patients manage diabetes, via Continuous Glucose Monitors (CGM).

adsilico

adsilico is developing an end-to-end in-silico trials solution based on virtual ‘synthetic patient populations that will provide better and safer medical devices earlier to patients, reduce costs and accelerate R&D timescales for medical device developers, contribute to animal welfare by reducing animal experimentation, reducing refining and partially replacing costly and potentially har

View Portfolio